Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1

by Ackerman, P., Cahn, P., Chabria, S., Clark, A., DeJesus, E., Diaz, R.S, Du, F., Garside, L., Gartland, M., Grossberg, R., Kozal, M., Krystal, M., Kumar, P., Lataillade, M., Mannino, F., Mendo Urbina, F., Molina, J.-M, Pierce, A., Wang, M.
Published 2022